Apricus Biosciences (APRI) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts APRI Hot Sheet
Join SI Premium – FREE
Apricus Biosciences (NASDAQ: APRI) reported Q3 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $1.23 million.
For earnings history and earnings-related data on Apricus Biosciences (APRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integer Holdings Corp (ITGR) Tops Q1 EPS by 2c ; Offers Guidance
- HarborOne Bancorp, Inc. (HONE) Tops Q1 EPS by 6c
- Ladder Capital (LADR) Tops Q1 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
